The last time Gilead Sciences (NASDAQ: GILD ) reported quarterly results, the biotech easily trounced analysts’ estimates. However, Gilead’s stock dropped due to a disappointing outlook for 2015.
On Thursday of this week, Gilead steps up to bat again with its first quarter results. Will investors be disappointed or delighted? Here are three things to watch that will likely make the difference.
Hey, check out all the research scientist jobs. Post your resume today!
